IMMX
Immix Biopharma Inc

4,301
Mkt Cap
$187.1M
Volume
1.11M
52W High
$5.57
52W Low
$1.34
PE Ratio
-7.07
IMMX Fundamentals
Price
$5.67
Prev Close
$4.84
Open
$4.93
50D MA
$3.35
Beta
1.08
Avg. Volume
628,191.84
EPS (Annual)
-$0.7641
P/B
22.22
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Immix Biopharma (NASDAQ:IMMX) Trading 4.5% Higher - What's Next?
Immix Biopharma (NASDAQ:IMMX) Shares Up 4.5% - What's Next...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Trading 4.5% Higher - What's Next?
Immix Biopharma (NASDAQ:IMMX) Shares Up 4.5% - What's Next...
MarketBeat·3d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Trading 4.5% Higher - What's Next?
Immix Biopharma (NASDAQ:IMMX) Shares Up 4.5% - What's Next...
MarketBeat·3d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Trading 4.5% Higher - What's Next?
Immix Biopharma (NASDAQ:IMMX) Shares Up 4.5% - What's Next...
MarketBeat·3d ago
News Placeholder
HC Wainwright Reduces Earnings Estimates for Immix Biopharma
Immix Biopharma, Inc. (NASDAQ:IMMX - Free Report) - Research analysts at HC Wainwright cut their FY2025 earnings per share (EPS) estimates for shares of Immix Biopharma in a research report issued on...
MarketBeat·23d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Announces Earnings Results, Misses Expectations By $0.05 EPS
Immix Biopharma (NASDAQ:IMMX - Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate...
MarketBeat·27d ago
News Placeholder
Immix Biopharma (IMMX) Upgraded to Buy: What Does It Mean for the Stock?
Zacks·6mo ago
News Placeholder
IMMX Stock Earnings: Immix Biopharma Misses EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips IMMX stock results show that Immix Biopharma missed analyst estimates for earnings per share the fourth quarter of 2023. The post IMMX...
InvestorPlace·2y ago
News Placeholder
Immix Biopharma, Inc. (NASDAQ:IMMX) Sees Large Growth in Short Interest
Immix Biopharma, Inc. (NASDAQ:IMMX - Get Free Report) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 316,600 shares, a...
Zolmax·2y ago
News Placeholder
Immix Biopharma Announces Major Comprehensive Cancer Center as Lead Site for NXC-201 AL Amyloidosis Clinical Trial
LOS ANGELES, CA, March 20, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) ( ImmixBio , Company , We or Us or IMMX ), a clinical-stage biopharmaceutical company trailblazing...
Globe Newswire·2y ago

Latest IMMX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.